Fig. 1From: Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR groupFrequencies of immunosuppressants ever used and highest therapy combination ever used per patient. GC glucocorticoids, CYC cyclophosphamide, AZA azathioprine, MTX methotrexate, MMF mycophenolate mofetil, RTX rituximab, DPA D-penicillamine, a-TNF anti-tumour necrosis factor, IMA imatinibBack to article page